Bonesupport Holding (BONEX.ST) Stock Analysis & AI Equity Report

Medical - Pharmaceuticals SEK Explore free reports

Bonesupport Holding (BONEX.ST) overview

Bonesupport Holding (BONEX.ST) stock analysis and AI equity research. For the latest completed financial year, 2025, Bonesupport Holding reported revenue of SEK 1,175m and operating profit of SEK 277m; the year-end share price was 188.00 SEK and market capitalisation was SEK 12,381m. Bonesupport Holding is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get Bonesupport Holding's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.

Key metrics & valuation multiples

Book valueSEK 867mFY 2025
Share price188.00 SEKFY 2025 year end
RevenueSEK 1,175mFY 2025
Operating profitSEK 277mFY 2025
Net earningsSEK 142mFY 2025
Market capitalisationSEK 12,381mFY 2025 year end

Figures updated on 2026-07-27. Data will be refreshed during report generation.

About Bonesupport Holding

BONESUPPORT Holding AB is a Scandinavian orthobiologics company that develops and commercializes CERAMENT, a range of injectable bioceramic bone graft substitutes used to treat fractures and bone voids caused by trauma, infection, disease or surgery. Its products are designed to remodel to host bone and can also elute drugs.

Generate the Bonesupport Holding report

Bonesupport Holding is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.

Generate fresh report — €50.00 Delivered by email, typically within about 30 minutes

Sources & methodology

Financial figures are sourced from Valuatum's financial model for Bonesupport Holding and represent the latest completed financial year (2025). See the methodology for the full Valuatum AI equity research framework.

Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.

Analyst reports on Bonesupport Holding

Each is this company's Valuatum report re-run with an analyst's own assumptions and published under their name. They are ordered by what other analysts said the work added over the engine's report — a score out of five from people who had to read it to give it.